(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone NEW

(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone 

It is a chemical compound with the molecular formula C12H19NO6 and the CAS number 1103738-19-7 . 

It is a white to yellow solid with a melting point of 122-124°C. 

It is an intermediate for the synthesis of sotagliflozin, a dual inhibitor of sodium-glucose cotransporter 1 (SGLT1) and sodium-glucose cotransporter 2 (SGLT2).

Sotagliflozin, also known as LX-4211 or Zynquista, is an oral antidiabetic drug that reduces glucose absorption in the gastrointestinal tract and glucose reabsorption in the kidney. 

It has been approved in the European Union for the treatment of type 1 diabetes mellitus as an adjunct to insulin therapy. 

It has also shown cardiovascular and renal benefits in patients with type 2 diabetes mellitus and chronic kidney disease or heart failure.